These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5075092)

  • 1. Effect of aspirin upon experimental coronary and non-coronary thrombosis and arrhythmia.
    Moschos CB; Lahiri K; Peter A; Jesrani MU; Regan TJ
    Am Heart J; 1972 Oct; 84(4):525-30. PubMed ID: 5075092
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation of microcirculatory thrombosis to thrombus in the proximal coronary artery: effect of aspirin, dipyridamole, and thrombolysis.
    Moschos CB; Lahiri K; Lyons M; Weisse AB; Oldewurtel HA; Regan TJ
    Am Heart J; 1973 Jul; 86(1):61-8. PubMed ID: 4268306
    [No Abstract]   [Full Text] [Related]  

  • 3. Actions and clinical status of platelet-suppressive agents.
    Didisheim P; Fuster V
    Semin Hematol; 1978 Jan; 15(1):55-72. PubMed ID: 341328
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection by aspirin against experimentally induced arterial thrombosis in dogs.
    Danese CA; Voleti CD; Weiss HJ
    Thromb Diath Haemorrh; 1971 Jun; 25(2):288-96. PubMed ID: 5568048
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-steroidal anti-inflammatory agents and coronary heart disease.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Acta Med Scand Suppl; 1980; 642():180-90. PubMed ID: 6935944
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet therapy.
    Turpie AG
    Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of atherosclerosis and thrombosis with aspirin.
    Wood L
    Lancet; 1972 Sep; 2(7776):532-4. PubMed ID: 4115584
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin inhibits the early myocardial release of thromboxane B2 and ventricular ectopic activity following acute coronary artery occlusion in dogs.
    Coker SJ; Ledingham IM; Parratt JR; Zeitlin IJ
    Br J Pharmacol; 1981 Apr; 72(4):593-5. PubMed ID: 7284679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.
    Mehta J
    JAMA; 1983 May; 249(20):2818-23. PubMed ID: 6341645
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of drugs of platelets and complications of vascular disease.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
    Danese CA; Haimov M
    Surgery; 1971 Dec; 70(6):927-34. PubMed ID: 5124672
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin dosage and antithrombotic effect.
    Clagett GP; Russo M; Hufnagel H; Collins GJ; Rich NM
    Surg Forum; 1979; 30():199-201. PubMed ID: 538593
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of aspirin on experimentally induced arterial thrombosis during the healing phase.
    Dyken ML; Campbell RL; Muller J; Feuer H; Horner T; King R; Kolar O; Solow E; Jones FH
    Stroke; 1973; 4(3):387-9. PubMed ID: 4713026
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental platelet aggregation and arterial thrombosis. Effect of aspirin].
    Bousser MG; Lecrubier C
    Nouv Presse Med; 1973 Jun; 2(25):1687-92. PubMed ID: 4718537
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG
    Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental arterial thrombosis. In vivo and in the vitro effects of aspirin and prostaglandin E1].
    Gautier JC; Samama M; Bousser MG
    Ann Med Interne (Paris); 1972 Oct; 123(10):849-52. PubMed ID: 4659243
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis.
    Jang IK; Gold HK; Ziskind AA; Fallon JT; Holt RE; Leinbach RC; May JW; Collen D
    Circulation; 1989 Apr; 79(4):920-8. PubMed ID: 2494006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac death prevention in post-myocardial infarction patients: a review.
    Boissel JP; Leizorovicz A; Faucomprez C
    Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.